A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling

Journal of Biomedical Materials Research - Part A

Volumn 75, Issue 2, 2005, Pages 324-332

  Savarino, L ^a   Benetti, D ^b   Baldini, N ^a   Tarabusi, C ^a   Greco, M ^a   Aloisi, R ^b   Frascarelli, S ^c   Fantozzi, R ^d   Dianzani, C ^d   Mian, M ^b  

^a Laboratory for Pathophysiology of Orthopaedic Implants   (Italy)

^b Gunther Research Srl   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Anthraquinones; Bone remodeling; Microradiography; Superoxide; X ray diffraction

Indexed keywords

DISEASES; GRANULATION; ORTHOPEDICS; RADIOGRAPHY; SULFUR COMPOUNDS; WEAR OF MATERIALS; X RAY DIFFRACTION ANALYSIS;

ANTHRAQUINONES; BONE REMODELING; MICRORADIOGRAPHY; SUPEROXIDES;

BONE;

ANTHRAQUINONE; BIOCHEMICAL MARKER; FORMYLMETHIONYLLEUCYLPHENYLALANINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; BONE REMODELING; CRYSTALLOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; MEDIATOR RELEASE; MICRORADIOGRAPHY; NEUTROPHIL; NONHUMAN; OSTEOLYSIS; PHAGOCYTOSIS; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; RAT; TRABECULAR BONE; X RAY DIFFRACTION;

ANIMALS; ANTHRAQUINONES; BONE REMODELING; FEMALE; HUMANS; NEUTROPHILS; OSTEOLYSIS; PROSTHESIS FAILURE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TIBIA; X-RAY DIFFRACTION;

EID: 26844514474     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30426     Document Type: Article

References (31)

1. Archibeck MJ, Jacobs JJ, Roebuck KA, Giant TT. The basic science of periprosthetic osteolysis. Instr Course Lect 2001;50:185-195.
2. Schmalzried TP, Callaghan JJ. Wear in total hip and knee replacements. J Bone Joint Surg Am 1999;81(1):115-136.
3. Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, Sibley R. Cellular profile and cytokine production at prosthetic interfaces: Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 1998;80(3): 531-539.
4. Bauer TW. Particles and periimplant bone resorption. Clin Orthop 2002;405:138-143.
5. Wang ML, Hauschka PV, Tuan RS, Steinbeck MJ. Exposure to particles stimulates superoxide production by human THP-1 macrophages and avian HD-11EM osteoclasts activated by tumor necrosis factor-alpha and PMA. J Arthroplasty 2002; 17(3):335-346.
6. Saleh K, Schwarz E. Osteolysis: Medical and surgical approaches. Clin Orthop 2004;427:138-147.
7. Yang S, Ries WL, Key LL Jr. Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int 1998;63(4):346-350.
8. Steinbeck MJ, Appel WH Jr, Verhoeven AJ, Karnovsky MJ. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol 1994; 126(3):765-772.
9. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine transcription in PTC. Am J Physiol 1999:277(5 Pt 2):F779-F789.
10. Hwa SY, Burkhardt D, Little C, Ghosh P. The effects of orally diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis. J Reumatol 2001;28(4):825-834.
11. Martel-Pelletier J, Mineau F, Jolicoeur F-C, Cloutier J-M, Pelletier J-P. In vitro effects of diacerein and rhein on interleukin 1 and tumor necrosis factor-A systems in human osteoarthritic synovium and chondrocytes. J Rheumatol 1998;25:753-762.
12. Mian M, Brunelleschi S, Tarli S, Rubino A, Benetti D, Fantozzi R, Zilletti L. Rhein: An anthraquinone that modulates superoxide anion production from human neutrophils. J Pharm Pharmacol 1987;39(10):845-847.
13. Goodman SB, Lind M, Song Y, Smith RL. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop 1998; 352:25-34.
14. Wozniak W, Markuszewski J, Wierusz-Kozlowska M, Wysocki H. Neutrophils are active in total joint implant loosening. Acta Orthop Scand 2004;75:549-553.
15. Fantozzi R, Brunelleschi S, Rubino A, Tarli S, Masini E, Mannaioni PF. FMLP-activated neutrophils evoke histamine release from mast cells. Agents Actions 1986;18(1-2):155-158.
16. Mian M, Benetti D, Aloisi R, Rosini S, Fantozzi R, Savarino L, Stea S, Donati ME, Paganetto G, Pizzoferrato A. Effects of orally administered bisphosphonates on bone loss in a disuse osteopenia model involving the rat. Clin Exp Rheumatol 1996; 14:619-624.
17. Savarino L, Cenni E, Stea S, Donati ME, Paganetto G, Moroni A, Toni A, Pizzoferrato A. X-ray diffraction of newly formed bone close to alumina or hydroxyapatite-coated femoral stem. Biomaterials 1993;14:900-905.
18. Savarino L, Stea S, Ciapetti G, Paganetto G, Donati ME, Alvergna P, Pizzoferrato A. Microstructural investigation of bone-cement interface. J Biomed Mater Res 1995;29(6):701-705.
19. Zhang X, Morham SG, Langenbach R, Young DA, Xing L, Boyce BF, Puzas EJ, Rosier RN, O'Keefe RJ, Schwarz EM. Evidence for a direct role of COX-2 in implant wear debris induced osteolysis. J Bone Miner Res 2001;16:660-670.
20. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109(11):1405-1415.
21. Millett PJ, Allen MJ, Bostrom MPG. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002;84:236-249.
22. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338-347.
23. Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, Puzas JE, Rosier RN, O'Keefe RJ, Boyce BF, Schwarz EM. In vivo RANK signaling blockade using the receptor activator of NF kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002; 17(2):192-199.
24. Ulrich-Vinther M, Carmody EE, Goater JJ, Søballe K, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg 2002;84A:1405-1412.
25. Mian M, Benetti D, Rosini S, Fantozzi R. Rhein reduces proteoglycan loss during the autolytic breakdown of cultured cartilage. Int J Tissue React 1989;11(3):117-122.
26. Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N. Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur J Pharmacol 2002; 448:81-87.
27. Dianzani C, Lombardi G, Collino M, Ferrara C, Cassone MC, Fantozzi R. Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J Leukoc Biol 2001;69:1013-1018.
28. Hukkanen M, Corbett SA, Batten J, Konttinen YT, McCarthy ID, Maclouf J, Santavirta S, Hughes SP, Polak JM. Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg Br 1997;79:467-474.
29. Wagner C, Kaksa A, Muller W, Denefleh B, Heppert V, Wentzensen A, Hansch GM. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: Cells recovered from the inflamed site lack chemotactic activity but generate superoxides. Shock 2004;22(2):108-115.
30. De Sanctis V, Savarino L, Stea S, Cervellati M, Ciapetti G, Tassinari L, Pizzoferrato A. Microstructural analysis of severe bone lesions in seven thalassemic patients treated with deferoxamine. Calcif Tissue Int 2000;67:128-133.
31. Douni E, Sfikakis PP, Haralambous S, Fernandes P, Kollias G. Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: Comparative analysis with dexamethasone, methotrexate and anti-TNF protocols. Arthritis Res Ther 2004;6(1):R65-R72.